logo

Sector: Pharmaceuticals & Biotechnology

|

Small Cap

Accretion Pharmaceuticals Share Price

ACCPL

160

-4.20(-2.56%)
NSE : ACCPL
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Accretion Pharmaceuticals Performance

Price Movement

₹160.00

₹160.00

₹160.00

Today's LowToday's High

1 Year Performance

₹160.00

₹53.80

₹171.80

52 Week Low52 Week High

Markets Today

High₹160.00
Low₹160.00
Open at₹160.00
Prev Close₹164.20
Volumes1.20 K
Avg Price₹160.00
Lower Circuit₹156.00
Upper Circuit₹172.40

Historical Performance

3M High₹171.80
3M Low₹91.00
1 Yr High₹171.80
1 Yr Low₹53.80
3 Yr High₹171.80
3 Yr Low₹53.80
5 Yr High₹171.80
5 Yr Low₹53.80

Summary

As of 28-07-2026 02:51, Accretion Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-164.20 (-100.00%) from the previous close of ₹164.2. The stock opened at ₹160 and traded between ₹160 and ₹160, with a total traded volume of 1200 shares. The company has a market capitalization of ₹182.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹171.8 and ₹53.8, respectively.

Accretion Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 18.9, and book value of ₹3.30. Profitability indicators show ROE of 17.67%.

Accretion Pharmaceuticals Ltd. technical indicators include Day RSI at 58.58, Day MFI at 77.45, Day ADX at 30.48. Additional indicators include Commodity Channel Index (CCI) at 64.5 and Williams %R at -41.64. Momentum indicators show Day MACD at 6.29, Day MACD Signal Line at 6.8, DayATR at 6.33. Rate of Change indicators for Accretion Pharmaceuticals Ltd. include ROC125 at 125.09 and ROC21 at 8.1.

Exponential moving averages include EMA5 at ₹165.2, EMA10 at ₹163.5, EMA12 at ₹162.7, EMA20 at ₹159.3, EMA26 at ₹156.4, EMA50 at ₹143.9, EMA100 at ₹123.9, EMA200 at ₹103.1. Simple moving averages include SMA5 at ₹165.2, SMA10 at ₹163.1, SMA20 at ₹161, SMA30 at ₹155.8, SMA50 at ₹143.8, SMA100 at ₹112.8, SMA150 at ₹101, SMA200 at ₹92.6.

Support levels for Accretion Pharmaceuticals are placed at First Support ₹161.90, Second Support ₹159.60, Third Support ₹157.05. Resistance levels are seen at First Resistance ₹166.75, Second Resistance ₹169.30, Third Resistance ₹171.60. Accretion Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 73.52%, FII holding at 0%, DII holding at 0%, public holding at 23.72%.

Accretion Pharmaceuticals Fundamentals

Market Cap
Below industry Median
182.50 Cr.
PE Ratio (TTM)
Below industry Median
18.90
Dividend Yield
0
Net Profit TTM
Net profit TTM
-
Net Profit Growth
Net profit TTM
-
PEG Ratio
-
ROE
60% decr over last year
17.67
Operating Revenue TTM
-
Operating Revenue Growth
Operating Revenue TTM
Book Value
Above industry Median
3.30
MFI
MFI Overbought
77.45
RSI
RSI is mid-range
58.58
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
3.30

Accretion Pharmaceuticals Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2024
Total Revenue17.10
Operating Expense12.70
Operating Profit4.40
Depreciation0.21
Interest0.37
Tax1.12
Net Profit2.77

Accretion Pharmaceuticals Technicals

Accretion Pharmaceuticals Ltd. EMA & SMA

160.00

-10.25 (-6.02%)

Bullish Moving Average

14

Bearish Moving Average

2

Day EMA5 ₹165.2
Day EMA10 ₹163.5
Day EMA12 ₹162.7
Day EMA20 ₹159.3
Day EMA26 ₹156.4
Day EMA50 ₹143.9
Day EMA100 ₹123.9
Day EMA200 ₹103.1

Accretion Pharmaceuticals Support and Resistance

Resistance

First Resistance₹166.75
Second Resistance₹169.30
Third Resistance₹171.60

Support

First Support₹161.90
Second Support₹159.60
Third Support₹157.05

Technical Indicators

Day RSI58.58
Day MFI77.45
Day ADX30.48
Day Commodity Channel Index64.50
William-41.64
Day MACD6.29
Day MACD Signal Line6.80
Day ATR6.33
Day ROC125125.09
Day ROC218.10

Accretion Pharmaceuticals Shareholding Pattern

Held ByJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoter73.573.573.573.573.5
FII2.21.2000
DII0.10002.8
Public24.225.326.526.523.7

Accretion Pharmaceuticals Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day4.8 K4.8 K100.00%
Week7.68 K7.92 K96.97%
1 Month19.77 K20.29 K97.46%
6 Month21.37 K23.97 K89.16%

Accretion Pharmaceuticals SWOT Analysis

Strengths17
Weakness5
Opportunity0
Threats0

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Highest Recovery from 52 Week Low

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Accretion Pharmaceuticals Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
No Record Found

Accretion Pharmaceuticals Stock Comparison

Financials
Price (₹)₹141.55₹558₹5.22₹111.80₹160₹15.84
% Change2.05%4.18%0.77%-0.18%-1.84%5.53%
Revenue TTM (₹ Cr)--₹69.99-₹287.68₹176.50
Net Profit TTM (₹ Cr)--₹-176.47-₹14.88₹27.81
PE TTM66.30--0.2013.1042.5028.70
1 Year Return-0.2236.63418-12.529.3764.95
ROCE-3.56-56.37--17.36

FAQ's on ACCPL

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy